DelSiTech is pleased to announce our participation to Glaucoma 360 event held at the Westin St. Francis, San Francisco on February 2-4. Glaucoma 360 is a series of three days of annual events uniting research, industry, and philanthropy to prevent vision loss from glaucoma and speed the cure.
Sustained release technologies are emerging as the choice for many drugs for effective delivery to the eye. DelSiTech Silica Matrix technology offers innovative solution as the next generation delivery platform to extend the durability of treatment. This unique technology can be administered in the form of eye drops and as an injection, creating versatility for many future applications.
Are you interested in meeting with us at the Glaucoma 360? Reach out here to schedule a call with our team.